Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn which credit cards offer the best rewards points and make informed choices to maximize your benefits. Start comparing today!
28,095 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
SpaceX’s long-anticipated S-1 lays out revenue and losses, yet key subscription and launch-cost details are absent, c...
ServiceNow and IBM unveiled a broader AI-driven collaboration aimed at modernizing aging enterprise apps, with soluti...
Investors are watching whether NVIDIA back business China could unlock a new revenue stream. This analysis covers sce...
Bitcoin faces first jobs-week as US labor data lands ahead of payrolls, guiding Fed bets and crypto volatility. Inves...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
An AI-led forecast suggests ripple (xrp) price prediction could push XRP to $500 by 2035, renewing debates about the ...
Walmart stock analysis: dip? signals can be confusing. This guide breaks down what a dip means for Walmart, the core ...
Amazon stock has swung in 2026, tempting buyers after a retreat. This guide explains how to evaluate a dip, set buyin...
As 2026 unfolds, smart glasses are poised for a pivotal year, led by Meta and Google. Apple sits on the sidelines wit...
The idea of Tesla merging with SpaceX has captivated investors and enthusiasts alike. This article breaks down what a...
XRP trades near $1.05 as on-chain MVRV metrics flash a rare setup. A breakout above stubborn resistance could unlock ...